103 related articles for article (PubMed ID: 35413730)
21. Algorithm to Identify Incident Epithelial Ovarian Cancer Cases Using Claims Data.
Huepenbecker SP; Zhao H; Sun CC; Fu S; He W; Giordano SH; Meyer LA
JCO Clin Cancer Inform; 2022 Mar; 6():e2100187. PubMed ID: 35297648
[TBL] [Abstract][Full Text] [Related]
22. Use of prescription drugs among women diagnosed with epithelial ovarian cancer in Denmark.
Pottegård A; Friis S; Verdoodt F; Dehlendorff C; Hallas J; Kjaer SK
Acta Obstet Gynecol Scand; 2018 Nov; 97(11):1332-1338. PubMed ID: 29932454
[TBL] [Abstract][Full Text] [Related]
23. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
[TBL] [Abstract][Full Text] [Related]
24. Temporal patterns of conditions and symptoms potentially associated with ovarian cancer.
Wynn ML; Chang S; Peipins LA
J Womens Health (Larchmt); 2007 Sep; 16(7):971-86. PubMed ID: 17903074
[TBL] [Abstract][Full Text] [Related]
25. Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival.
Williams MG; Bandera EV; Demissie K; Rodríguez-Rodríguez L
Obstet Gynecol; 2009 Apr; 113(4):783-789. PubMed ID: 19305320
[TBL] [Abstract][Full Text] [Related]
26. Ovarian cancer: can we make the clinical diagnosis earlier?
Smith LH; Morris CR; Yasmeen S; Parikh-Patel A; Cress RD; Romano PS
Cancer; 2005 Oct; 104(7):1398-407. PubMed ID: 16116591
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
28. Association of Medicare and Medicaid insurance with increasing primary care-treatable emergency department visits in the United States.
Pukurdpol P; Wiler JL; Hsia RY; Ginde AA
Acad Emerg Med; 2014 Oct; 21(10):1135-42. PubMed ID: 25308137
[TBL] [Abstract][Full Text] [Related]
29. Association of a Care Coordination Model With Health Care Costs and Utilization: The Johns Hopkins Community Health Partnership (J-CHiP).
Berkowitz SA; Parashuram S; Rowan K; Andon L; Bass EB; Bellantoni M; Brotman DJ; Deutschendorf A; Dunbar L; Durso SC; Everett A; Giuriceo KD; Hebert L; Hickman D; Hough DE; Howell EE; Huang X; Lepley D; Leung C; Lu Y; Lyketsos CG; Murphy SME; Novak T; Purnell L; Sylvester C; Wu AW; Zollinger R; Koenig K; Ahn R; Rothman PB; Brown PMC;
JAMA Netw Open; 2018 Nov; 1(7):e184273. PubMed ID: 30646347
[TBL] [Abstract][Full Text] [Related]
30. Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage study.
Tracey E; Hacker NF; Young J; Armstrong BK
Int J Gynecol Cancer; 2014 Sep; 24(7):1232-40. PubMed ID: 25153678
[TBL] [Abstract][Full Text] [Related]
31. Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries.
Crafton SM; Cohn DE; Llamocca EN; Louden E; Rhoades J; Felix AS
Cancer; 2020 Mar; 126(6):1217-1224. PubMed ID: 31774553
[TBL] [Abstract][Full Text] [Related]
32. Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum.
Roder D; Davy M; Selva-Nayagam S; Paramasivam S; Adams J; Keefe D; Miller C; Powell K; Fusco K; Buranyi-Trevarton D; Oehler MK
BMJ Open; 2019 Feb; 9(2):e024036. PubMed ID: 30782891
[TBL] [Abstract][Full Text] [Related]
33. Screening program in ovarian cancer: A logical step in clinical management? A meta-analysis.
Marchetti C; De Felice F; Perniola G; Lecce F; Vertechy L; Monti M; Musio D; Muzii L; Tombolini V; Benedetti Panici P
Curr Probl Cancer; 2018; 42(2):235-240. PubMed ID: 29433824
[TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
[TBL] [Abstract][Full Text] [Related]
35. Insurance Differences in Preventive Care Use and Adverse Birth Outcomes Among Pregnant Women in a Medicaid Nonexpansion State: A Retrospective Cohort Study.
Taylor YJ; Liu TL; Howell EA
J Womens Health (Larchmt); 2020 Jan; 29(1):29-37. PubMed ID: 31397625
[No Abstract] [Full Text] [Related]
36. Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer.
Chambers LM; Kuznicki M; Yao M; Chichura A; Gruner M; Reizes O; Debernardo R; Rose PG; Michener C; Vargas R
Gynecol Oncol; 2020 Dec; 159(3):699-705. PubMed ID: 32950250
[TBL] [Abstract][Full Text] [Related]
37. Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies.
Huang T; Poole EM; Okereke OI; Kubzansky LD; Eliassen AH; Sood AK; Wang M; Tworoger SS
Gynecol Oncol; 2015 Dec; 139(3):481-6. PubMed ID: 26449316
[TBL] [Abstract][Full Text] [Related]
38. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
39. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies.
Barnard ME; Poole EM; Curhan GC; Eliassen AH; Rosner BA; Terry KL; Tworoger SS
JAMA Oncol; 2018 Dec; 4(12):1675-1682. PubMed ID: 30286239
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with persistent high health care utilization in managed Medicaid.
Banerjee S; Alabaster A; Kipnis P; Adams AS
Am J Manag Care; 2021 Aug; 27(8):340-344. PubMed ID: 34460176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
